Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Glucose sensor developer Know Labs turns its AI toward a potential new moneymaker: NFTs
https://www.fiercebiotech.com/medtech/glucose-sensor-developer-know-labs-turns-its-ai-toward-a-potential-new-moneymaker-nfts
“We were stunned to discover that the AI engine we have developed can, in addition to identifying molecules noninvasively, also create unique, digital patterns from our test data,” Know Labs CEO Phil Bosua said in a statement.
The company said it has sold over 1,000 NFTs to collectors so far, collecting more than 1,000 Ethereum, a blockchain-based cryptocurrency. Know Labs also expects to generate additional revenue from NFT sales in the current fiscal quarter and to report the earnings to the Securities and Exchange Commission in February 2022 filings.
The wearable UBand is currently being submitted for FDA review, while the pocketable KnowU device is slated to undergo clinical studies. The company also plans to launch a “200-participant internal clinical trial” to help refine its AI algorithms, Erickson said.
What devices like Apple, Google smartwatches are beginning to display about our health
https://www.cnbc.com/2021/12/12/what-apple-google-smartwatches-are-learning-about-our-health.html
The global market for wearable health and fitness devices — including sensor-laden watches, wrist bands, rings, skin patches, eyeglasses and clothing — reached more than $36 billion in 2020 and is projected to reach over $100 billion by 2028.
That has been fueled by the growth in popularity of wearables from Apple, Amazon, Google, and other tech and wellness companies that evolved the devices beyond just basic fitness trackers.
Now there is an increasing interest in incorporating a wider range of medical data from these trackers into the digital health ecosystem.
Rockley Photonics Holdings Limited
Dr. Andrew G. Rickman O.B.E., OBE, Ph.D. Founder, Chairman, Pres & CEO
https://www.brainshark.com/1/player/clientcommunications?pi=zGjzqQF6VzTBFiz0&r3f1=566c12414d40180a5a0e6a10504e474d570649760956565f475c050f6b125a535a41565b046b0b1a5845474b011429075b591e525710146108415c474b4a1b142b95a3c0909f858d9298c5b4d58e&fb=0
Photonics-Based Measurement of Core Body Temperature
https://rockleyphotonics.com/wp-content/uploads/2021/12/Rockley-Photonics-Photonics-Based-Measurement-of-Core-Body-Temperature.pdf
Rockley Photonics Announces Results of Preliminary Human Studies Involving Measurement of Core Body Temperature
https://investors.rockleyphotonics.com/news/news-details/2021/Rockley-Photonics-Announces-Results-of-Preliminary-Human-Studies-Involving-Measurement-of-Core-Body-Temperature/default.aspx
OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)-- Rockley Photonics (NYSE: RKLY), today announced that the company has successfully completed the first stages of its preliminary human studies examining the measurement of core body temperature using its non-invasive biomarker sensing platform.
Abbott sues DexCom over glucose-monitoring patent settlement, license
https://www.reuters.com/legal/transactional/abbott-sues-dexcom-over-glucose-monitoring-patent-settlement-license-2021-12-02/
An Abbott Laboratories subsidiary focused on diabetes care sued rival DexCom in Delaware federal court for allegedly violating a 2014 settlement agreement and asked the court to declare that Abbott doesn't infringe its patents.
The lawsuit filed Wednesday is sealed, and the motion to seal says it relates to Abbott's Freestyle Libre continuous glucose monitoring system.
Chicago-based Abbott made more than $2.6 billion from worldwide sales of Freestyle Libre products last year, according to a filing with the U.S. Securities and Exchange Commission. DexCom's flagship G6 system is a rival to the Freestyle Libre.
Painless continuous blood sugar monitoring on the horizon for US$199 thanks to the K'Watch Glucose from PKVitality
https://www.notebookcheck.net/Painless-continuous-blood-sugar-monitoring-on-the-horizon-for-US-199-thanks-to-the-K-Watch-Glucose-from-PKVitality.582622.0.html
The K’Watch Glucose smartwatch from PKVitality is currently undergoing clinical trials in the US. The device promises painless continuous glucose monitoring for diabetics and utilizes a replaceable K’apsul with SkinTaste technology to take blood sugar readings. The K’Watch Glucose should be priced at US$199/€199 upon release.
The device, which looks like a typical smartwatch, is undergoing a clinical investigation involving 35 patients, with the study completion date expected to be June 30, 2022. PKVitality expects to have the K’Watch Glucose on the market at some point in 2022 or 2023 depending on the region.
Levels Health review: optimize your fitness with a $400 glucose tracker
https://www.theverge.com/platform/amp/22794594/levels-health-glucose-fitness-tracker-review
Levels Health is a new product and service — currently in late-stage beta but gettable by the public — designed to monitor your body’s glucose response to different stimuli, like exercise and stress and especially the foods you eat. It’s sort of like a Fitbit for your metabolic health, and it currently costs a hefty $400 for the one-month program. It’s aimed toward athletes and the health-conscious who are looking for everything from optimum performance to simply staying healthy.
Pain-free non-invasive blood sugar monitor for use with any compatible smart device in the Afon pipeline
https://www.notebookcheck.net/Pain-free-non-invasive-blood-sugar-monitor-for-use-with-any-compatible-smart-device-in-the-Afon-pipeline.581938.0.html
Afon Technology, which is based in Monmouthshire in Wales, is working on a pain-free, non-invasive blood glucose monitor that can be utilized alongside a compatible smart device such as a watch, phone, or tablet. The Afon sensor is worn on the inside of the wrist and can measure critical data without having to break the skin. This would be a great relief to those suffering from diabetes who have to rely on painful fingertip pricking to measure their blood sugar levels.
Apple, Fitbit emerge as first responders for healthcare
https://amp.usatoday.com/amp/8721439002
In a couple of years, your wearables likely will be monitoring your blood pressure. And in just a few years after that, they may even be able to keep tabs on your blood sugar. But they probably won’t share any of the measurements with you.
Of course, those two metrics are vitally important. Nearly half of all adults in the country have high blood pressure, and more than 500,000 Americans die of it each year. One in three either have prediabetes or diabetes, the seventh leading cause of death.
But after years of bombarding us with incessant streams of step counts, hours of sleep and heart rate measurements, wearables makers are coming to understand that they can put together a far more useful, compelling look at our health with less data. So they increasingly are offering more holistic views of our activity, and how they interrelate. Like, for example, the impact of the steps you logged yesterday on your sleep quality last night.
“To me, success is not measured by whether I can give you a metric,” Eric Friedman, co-founder and CTO of Fitbit, told me. “It’s whether I can help you become healthier.”
Alleged Apple Watch 8 design leak looks blah — but it’s the insides that count
https://www.tomsguide.com/amp/news/alleged-apple-watch-8-design-leak-look-blah-but-its-the-insides-that-count
Back in May, SEC documents revealed that Apple was the largest customer of a company called Rockley Photonics, which specializes in sensors for medical equipment, designed to measure a whole host of metrics including lactate, alcohol, body temperature, carbon monoxide, blood oxygen, blood pressure and blood glucose. At the time, CEO Andrew Rickman stated that he expected the company’s technology to be in consumer products in 2022.
While LeaksApplePro believes 2022 could be too early for the long rumored blood sugar measurement, it wouldn’t be too surprising if one or more of the other sensors make their debut in the Apple Watch 8. And that, along with possible upgrades to performance and battery life, could be a game changer.
The Oura Ring is on a quest to become the ultimate health wearable
It got famous by tracking sleep. Now it’s aiding research on COVID-19, women’s health, and more—and wants to parlay the learnings into a bevy of new features.
https://www.fastcompany.com/90698937/oura-ring-third-generation
Rockley Photonics Holdings
Bernstein CGM Disruptors Conference
November 19, 2021
Andrew Rickman, CEO
https://s28.q4cdn.com/749577678/files/doc_presentation/2021/11/RKLY-CGM-Conference-Presentation-Final-2021-11-19.pdf
Rockley Photonics Unveils Collaborative Clinical Research Initiative for Remote Patient Monitoring and Diagnosis
https://finance.yahoo.com/news/rockley-photonics-unveils-collaborative-clinical-140000557.html
Rockley Photonics (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, formed a strategic relationship to incorporate Rockley’s non-invasive biomarker sensing platform into potential clinical and healthcare research studies. Rockley will be working with the Icahn School of Medicine at Mount Sinai in New York, NY, part of the Mount Sinai Health System, for potential collaboration in future research studies.
The initiative aims to incorporate the next generation of non-invasive biomarker sensing in a series of studies to evaluate the use of wristbands and other wearables for a variety of potential applications, including remote monitoring and diagnosis. Rockley aims to create new opportunities for its photonics-based sensing platform in healthcare and medical applications and help expand the future use of real-time, non-invasive biomarker sensing for people around the globe.
Oura Ring 3 review: Unobtrusive 24/7 health tracking with more to come in 2022
Smartwatches have added advanced health and wellness tracking features, but have limited battery life and take up wrist space. Oura's Ring Generation 3 lasts for several days and captures data without you thinking much about the tracker.
https://www.zdnet.com/google-amp/article/oura-ring-3-review/
Oura Ring 3 review: Unobtrusive 24/7 health tracking with more to come in 2022
Smartwatches have added advanced health and wellness tracking features, but have limited battery life and take up wrist space. Oura's Ring Generation 3 lasts for several days and captures data without you thinking much about the tracker.
https://www.zdnet.com/google-amp/article/oura-ring-3-review/
Know Labs will be presenting its technology and product portfolio at DiabetesMine Innovation Days. After the presentation, our CEO, Phil Bosua, will be addressing questions
You can register for the event at https://lnkd.in/eWXj4PMN.
https://www.eventbrite.com/e/fall-2021-diabetesmine-innovation-days-innovation-summit-d-data-exchange-tickets-162087428863
Rockley Photonics Holdings Ltd (RKLY) Q3 2021 Results - Earnings Call
https://seekingalpha.com/article/4469804-rockley-photonics-holdings-ltd-rkly-ceo-andrew-rickman-on-q3-2021-results-earnings-call
In August, we completed our business combination with SE Health, and began trading on the New York Stock Exchange. Through the process, we raised $168 million which will help us to develop our consumer wearable solution while we work towards its commercialization.
Rockley's proprietary silicon photonics-based later technology significantly expands the range of biomarkers that can be detected and messed continually, and noninvasively be on the capabilities of current LED-based sensors. This expanded range includes key biomarkers like cold body temperature, blood pressure, poly hydration, alcohol, actin and glucose trends, amongst others.
Today, we announced new partnerships with 5 global consumer electronics companies, including 4 of the top 10 risk-based wearable companies, strengthening our position in the market by adding some of the most prominent companies in the smartphone and wearables market, 6 of the world's top 10 manufacturers of smartwatches and wrist bands now look to our platform as an important part of their health and wellness strategies.
In med tech, we recently signed partnerships with 2 of the world's largest medical device companies.
7 diabetes treatment innovations to look out for on World Diabetes Day
https://www.drugdeliverybusiness.com/7-diabetes-treatment-innovations-to-look-out-for-on-world-diabetes-day/
World Diabetes Day — Nov. 14 — centers around raising awareness for those with diabetes.
This year, that aim remains the same, and medical technology companies continue to look for ways to continue improving the management of the metabolic disease.
Some of those treatments involve insulin, which was discovered as a treatment for diabetes in 1922 and remains a vital part of the standard of care. World Diabetes Day falls on Nov. 14 because it is the birthday of Frederick Banting, one of the scientists involved in discovering insulin as a treatment for diabetes.
However, while many medtech companies look for ways to make insulin accessible and efficient in treating diabetes, others are innovating treatment avenues outside of insulin. Regardless of the path chosen, all have created intriguing options for managing and treating diabetes. Here are seven innovations in diabetes treatment that are worth keeping an eye on:
Needle-free glucose monitoring a step closer for diabetics
https://medicalxpress.com/news/2021-11-needle-free-glucose-closer-diabetics.html
All-in-One POGO Automatic Glucose Meter Finally Available
https://www.healthline.com/diabetesmine/pogo-automatic-glucose-meter
Fitbit rolls out ECG, blood glucose tracking tool in India
https://www.thenewsminute.com/article/fitbit-rolls-out-ecg-blood-glucose-tracking-tool-india-157494
Fitbit users living with diabetes, will be able to use a new blood glucose tracking tool in the Fitbit app to see how their glucose levels change throughout the day and react to other health metrics such as physical activity, sleep and nutrition, to help better manage their holistic health all in one place.
Huawei’s blood pressure tracking reportedly to land this month
https://gadgetsandwearables.com/2021/11/01/huawei-blood-pressure-watch/
Huawei’s blood pressure tracking watch will reportedly land in the weeks ahead. The timepiece has already snagged an EU trademark patent. This reveals it will be called Watch D and that it will have a global launch.
There are very few timepieces right now that can monitor for blood pressure. The Samsung line is one exception although it does require calibration and the readings are only on-demand. But it looks like the tide is slowly shifting.
We reviewed recently Aktiia, a blood pressure monitoring bracelet. It automatically captures readings multiple times per day via an optical sensor. Other companies are looking to get in on the game as well.
Valencell has announced at CES 2021 that its optical sensors have been upgraded to capture blood pressure readings from the wrist with cuff-like accuracy. The tech is expected to debut in the coming months.
There’s also the next generation tech that a number of companies such as Apple, Zepp Health, Withings and Samsung are exploring with Rockley Photonics. The difference between these sensors and the ones typically used today is that higher wavelengths are utilized in addition to those on the visible spectrum. The miniature Spectrometer-on-chip is apparently capable of capturing info on blood oxygen, hydration, heart rate, heart rate variability, core body temperature, breath rate, blood pressure, hydration, glucose and more. Exciting times are clearly ahead in the wearable tech space.
Device used by many diabetics at center of wrongful death lawsuit in Georgia
The FDA has received more than half a million complaints about the Dexcom G6, but has no plans to take action.
https://www.11alive.com/amp/article/news/investigations/the-reveal/diabetes-device-wrongful-death-lawsuit-in-georgia/85-d7e35c61-f091-4bb9-8e1c-da7616b0e027
Dexcom Reports Third Quarter 2021 Financial Results
https://finance.yahoo.com/news/dexcom-reports-third-quarter-2021-200200293.html
Revenue grew 30% versus the same quarter of the prior year to $650.2 million on a reported basis and 28% on an organic1 basis
Received FDA clearance for two key software solutions that enhance Dexcom’s connected ecosystem:
The Dexcom real-time API makes it possible for third-party developers to integrate real-time CGM data into their digital health apps and devices, ultimately offering Dexcom users a greater variety of options in where and how they engage with their glucose data.2
The Dexcom app-in-app module directly integrates with third party healthcare apps, making managing diabetes easier for Type 2 Non-intensive insulin therapy (NIIT) users by enabling a convenient, single-app experience.
UArizona researchers develop wearable device that can detect diseases
https://www.azfamily.com/news/health/uarizona-researchers-develop-wearable-device-that-can-track-diseases/article_86ae4f96-3783-11ec-87f5-2f4ad271007a.amp.html
TUCSON, AZ (3TV/CBS 5) - Engineers at the University of Arizona have created a new medical tech that can help detect disease and deterioration in older adults. It’s a wearable device, but it’s much smaller than a watch or a fitness tracker.
The wearable medical device is smaller than a dime and is far more accurate than any fitness tracker that sits on your wrist or in your pocket.
“The vision for the device is ultimately, you put this on, and we can detect what’s wrong with you,” said biomedical engineer Philipp Gutruf, who leads the project. The team starts by doing a body scan of a patient. From there, they 3D print a mesh band to hold the device in place.
Apple's suppliers are currently developing components for next-generation sensors in the Apple Watch Series 8 that will allow users to measure their blood glucose level, according to a new report.
https://www.macrumors.com/2021/10/25/apple-watch-series-8-blood-glucose-sensors/
According to a paywalled report from DigiTimes, Apple and its suppliers have begun working on short-wavelength infrared sensors, a commonly used sensor type for health devices. The new sensors, likely to be fitted on the back of the Apple Watch, will enable the device to measure the amount of sugar in a wearer's blood.
Wearable, Non-Invasive Sensor Measures Glucose in Sweat
https://www.medgadget.com/2021/10/wearable-non-invasive-sensor-measures-glucose-in-sweat.html
Scientists at Penn State University developed a wearable glucose monitor that can non-invasively measure glucose levels within sweat in real time. The low-cost sensor consists of laser-induced graphene and a nickel-gold alloy that can detect the very low levels of glucose in sweat without the use of enzymes. The sensor contains a microfluidic chamber into which sweat is drawn, and then an alkaline solution reacts with the glucose in the sweat, causing a reaction in the alloy and a substantial electrical signal.
This Is Why The Health Care Industry Is Ripe For Disruption
Laboratory Update - October 6, 2021
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
https://techcrunch.com/2021/10/04/graphwear-closes-20-5m-series-b-for-a-needle-free-nanotech-powered-glucose-monitor/amp/
“The Holy Grail problem has been: can you really know what is happening in your blood without using things to prick your skin and draw blood out,” says Ursheet Parikh the co-leader of Mayfield’s engineering biology investment practice. “We think GraphWear has made progress and is likely to be one of the first companies to actually bring a product that can get to hundreds of millions of people.”
Know Labs unveils pocket-sized glucose monitor that swaps fingersticks for radiofrequency sensors
https://www.fiercebiotech.com/medtech/know-labs-unveils-pocket-sized-glucose-monitor-swaps-fingersticks-for-radiofrequency
Know Labs is now planning on performing human clinical trials of its Bio-RFID technology to support its regulatory submissions for the UBand, and then the KnowU. The Seattle-based company said it expects to begin the FDA pre-approval process for the KnowU monitor sometime next year.
That process won’t slow down Know Labs’ efforts to commercialize the UBand, which have already begun, according to founder Ron Erickson. The KnowU not only uses the same technology as the wearable model but is also “faster to build and commercialize, therefore accelerating our time to launch,” Erickson explained.
Form 4 - filed by Know Labs, Inc.
https://newsfilter.io/a/82c2352bc1000d684016f6b31ce3daca
Ronald P Erickson bought 5,000 shares @ $2.53 a share.
reddit - Post Apple Event: Don't Sell
Recently Ming-Chi Kuo, an analyst at TF Securities who has a 76.6% accuracy rating, briefly commented on the Apple Watch Series 8 (2022) and AirPods.
https://www.reddit.com/r/rkly/comments/pmoefq/apple_event_dont_sell/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
CoG - Hybrid Glucometer
Meet The World’s First Hybrid, Non-Invasive Glucometer
Medically Tested & Clinicly Proven.
CE Approved. FDA Pending
https://www.cnogacare.co/cog-hybrid-glucometer
Wearables go invisible with the launch of Whoop 4.0
https://www.techradar.com/amp/news/wearables-go-invisible-with-the-launch-of-whoop-40
Never Offline
The Apple Watch is just the start. How wearable tech will change your life—like it or not
https://time.com/3326576/never-offline/
USPTO Trademarks › Know Labs, Inc. › U Application #90901869
https://uspto.report/TM/90901869
Mark For: U™ trademark registration is intended to cover the categories of wearable activity trackers, namely, multifunctional wearable electronic device for measuring, monitoring, displaying and uploading to the internet information relating to health; computer software for wireless data communication for receiving, processing, transmitting and displaying information related to health; portable electronic devices for measuring and monitoring blood properties not for medical use; sensors for measuring and monitoring blood properties, not for medical use.
FYI - Know Labs, Inc. Proxy Statement - Notice of the 2021 Annual Meeting of Stockholders
https://app.quotemedia.com/data/downloadFiling?webmasterId=102291&ref=116092455&type=HTML&symbol=KNWN&companyName=Know+Labs+Inc&formType=PRE+14A&formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&dateFiled=2021-08-20&CK=1074828
2. To approve an amendment to the Company’s Articles of Incorporation to increase the authorized shares of common stock (“Common Stock”) from 100,000,000 to 200,000,000 shares
Rockley Photonics Holdings, Ltd. (RKLY) CEO Andrew Rickman on Q2 2021 Results
https://seekingalpha.com/article/4449932-rockley-photonics-holdings-ltd-rkly-ceo-andrew-rickman-on-q2-2021-results-earnings-call
This goal in mind, we've been able to shrink a laboratory spectrophotometer-on-a-chip creating a clinic on the wrist. Are clearly on the wrist digital health sensor system has the potential to monitor multiple biomarkers, including core body temperature, blood pressure, body hydration, alcohol, lactate and glucose amongst others. Our technology is designed to be worn anywhere on your body where there is blood perfusion. We believe this is a game changer for wearables in both consumer and medical devices.
These are important milestones that will help to prepare us for the commercial launch of our product offering, which we expect to begin in 2022.